Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates ... and his new top vaccines official, Dr. Vinay Prasad. Vaccine manufacturers will need to ...

The FDA says the new approach will aim to balance a timely approval process for vaccines, while also weighing “the need for ...

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC has historically set vaccine recommendations, while the FDA determines which ...

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene therapies, and blood supply.

At this point, the additional doses offer “uncertain” benefits to many young and middle-aged people who have already been vaccinated or have had Covid, Dr. Vinay Prasad, the F.D.A.’s vaccine ...

The question on many minds among FDA rank-and-file in attendance was: Which Prasad would show up? The 2010s Prasad -- a ...

FDA Commissioner Marty Makary and top U.S. vaccines regulator Vinay Prasad wrote ... six previous doses of a Covid-19 vaccine will benefit from the seventh dose,” Prasad and Makary wrote.

Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health leadership.